Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin-Reference-Cited by-同舟云学术

Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin

Published:2022-06-03 Issue:9 Volume:29 Page:5462-5473
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Martin Robert C. G.,Simo Kerri A.,Hansen Paul,Rocha Flavio,Philips Prejesh,McMasters Kelly M.,Tatum Clifton M.,Kelly Lawrence R.,Driscoll Michael,Sharma Vivek R.,Crocenzi Todd S.,Scoggins Charles R.

Funder

BTG/Biocompatibles

Boston Scientific Corporation

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-022-11932-3.pdf

Reference30 articles.

1. American Cancer Society Cancer Statistics 2021 Report. J Nucl Med. 2021;62(3):12.

2. Rizvi S, Khan S, Hallemeier C, Kelley R, Gores G. Cholangiocarcinoma—evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15(2):95–111.

3. Benson A, D’angelica M, Abbott D, et al. Hepatobiliary cancers, version 2.2021, Nccn clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(5):541–65.

4. Valle J, Wasan H, Palmer Dh, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. New Engl J Med. 2010;362(14):1273–81.

5. Kato A, Shimizu H, Ohtsuka M, et al. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study. Ann Surg Oncol. 2013;20(1):318–24.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intra-arterial locoregional therapies for Intrahepatic Cholangiocarcinoma;Expert Review of Gastroenterology & Hepatology;2024-09-09

2. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer;ESMO Open;2024-08

3. Comparison of efficacy and safety of conventional transarterial chemoembolization and drug-eluting bead transarterial chemoembolization in unresectable intrahepatic cholangiocarcinoma: A multicenter retrospective cohort study;European Journal of Radiology;2024-07

4. Development of machine learning models for patients in the high intrahepatic cholangiocarcinoma incidence age group;BMC Geriatrics;2024-06-25

5. Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT);European Journal of Cancer;2024-05